Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad G Rusthoven

Showing results (41-50 of 123) with videos related to

Pageof 13
Sort By:
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Post-treatment mortality after definitive chemoradiotherapy versus trimodality therapy for locally advanced non-small cell lung cancerWaqar Haque, Vivek Verma, E Brian Butler, et al.
American Journal of Hematology|February 8, 2016
Improved survival with combined modality therapy in the modern era for primary mediastinal B-cell lymphomaMatthew W Jackson, Chad G Rusthoven, Bernard L Jones, et al.
Clinical and Translational Radiation Oncology|December 9, 2020
Stereotactic radiosurgery (SRS) - A new normal for small cell lung cancer?Ian Pereira, Ben Slotman, Chad G Rusthoven, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2024
Prophylactic Cranial Irradiation for Patients With SCLC-A New Perspective in the Immunotherapy EraAntonin Levy, Chad G Rusthoven, Paul D Brown, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Association between intensity modulated radiotherapy and survival in patients with stage III non-small cell lung cancer treated with chemoradiotherapyMatthew Koshy, Renuka Malik, Michael Spiotto, et al.
Urologic Oncology|December 25, 2015
Survival outcomes of radiotherapy with or without androgen-deprivation therapy for patients with intermediate-risk prostate cancer using the National Cancer Data BaseArya Amini, Chad G Rusthoven, Bernard L Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|June 9, 2019
Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation TherapyColton J Ladbury, Chad G Rusthoven, D Ross Camidge, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2015
Survival Outcomes of Whole-Pelvic Versus Prostate-Only Radiation Therapy for High-Risk Prostate Cancer Patients With Use of the National Cancer Data BaseArya Amini, Bernard L Jones, Norman Yeh, et al.
Cancer|September 21, 2016
National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinomaDavid J Sher, Chad G Rusthoven, Saad A Khan, et al.
Cancer Journal (Sudbury, Mass.)|July 22, 2016
Treatment Selection and Survival Outcomes With and Without Radiation for Unresectable, Localized Intrahepatic CholangiocarcinomaMatthew W Jackson, Arya Amini, Bernard L Jones, et al.
Pageof 13

Showing results (41-50 of 123) with videos related to

Sort By:
Pageof 13
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Post-treatment mortality after definitive chemoradiotherapy versus trimodality therapy for locally advanced non-small cell lung cancerWaqar Haque, Vivek Verma, E Brian Butler, et al.
American Journal of Hematology|February 8, 2016
Improved survival with combined modality therapy in the modern era for primary mediastinal B-cell lymphomaMatthew W Jackson, Chad G Rusthoven, Bernard L Jones, et al.
Clinical and Translational Radiation Oncology|December 9, 2020
Stereotactic radiosurgery (SRS) - A new normal for small cell lung cancer?Ian Pereira, Ben Slotman, Chad G Rusthoven, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2024
Prophylactic Cranial Irradiation for Patients With SCLC-A New Perspective in the Immunotherapy EraAntonin Levy, Chad G Rusthoven, Paul D Brown, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Association between intensity modulated radiotherapy and survival in patients with stage III non-small cell lung cancer treated with chemoradiotherapyMatthew Koshy, Renuka Malik, Michael Spiotto, et al.
Urologic Oncology|December 25, 2015
Survival outcomes of radiotherapy with or without androgen-deprivation therapy for patients with intermediate-risk prostate cancer using the National Cancer Data BaseArya Amini, Chad G Rusthoven, Bernard L Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|June 9, 2019
Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation TherapyColton J Ladbury, Chad G Rusthoven, D Ross Camidge, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2015
Survival Outcomes of Whole-Pelvic Versus Prostate-Only Radiation Therapy for High-Risk Prostate Cancer Patients With Use of the National Cancer Data BaseArya Amini, Bernard L Jones, Norman Yeh, et al.
Cancer|September 21, 2016
National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinomaDavid J Sher, Chad G Rusthoven, Saad A Khan, et al.
Cancer Journal (Sudbury, Mass.)|July 22, 2016
Treatment Selection and Survival Outcomes With and Without Radiation for Unresectable, Localized Intrahepatic CholangiocarcinomaMatthew W Jackson, Arya Amini, Bernard L Jones, et al.
Pageof 13